Breaking News Instant updates and real-time market news.

ACAD

ACADIA

$30.71

-1.1 (-3.46%)

07:30
10/04/16
10/04
07:30
10/04/16
07:30

ACADIA reinstated with a Market Perform at Leerink

Leerink analyst Paul Matteis resumed coverage of ACADIA with a Market Perform rating and $34 price target.

ACAD ACADIA
$30.71

-1.1 (-3.46%)

06/22/16
06/22/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Tesla (TSLA) downgraded to Perform from Outperform at Oppenheimer with analysts led by Colin Rusch saying they do not view the acquisition of Solar City (SCTY) as the best use of Tesla's capital and human resources given the potential returns on capital possible in the electric industry versus the potential leverage in Tesla's auto platform. 2. SolarCity downgraded to Hold from Buy at Stifel with analyst Sven Eenmaa saying the risk/reward looks balanced in the wake of Tesla's bid. 3. AMC Networks (AMCX) downgraded to Equal Weight from Overweight at Morgan Stanley with analyst Ryan Fiftal saying 2016 new show launches have missed expectations, making it unlikely the company can grow EBITDA beyond 2016 as declining Walking Dead ratings pressure the top-line. 4. ACADIA (ACAD) downgraded to Neutral from Buy at BofA/Merrill with the firm citing valuation. 5. McDonald's (MCD), Wendy's (WEN), Papa John's (PZZA) and Domino's Pizza (DPZ) downgraded to Neutral from Buy at Nomura. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
06/24/16
06/24/16
NO CHANGE

Needham sees Brexit making EU drug reviews 'less efficient, more expensive'
Needham analyst including Alan Carr, Chad Messer, Danielle Brill and Esther Pang noted that if Article 50 is invoked following the Brexit vote, the European Medicines Agency will need to move out of its current base in London and the U.K. will need to create its own separate regulatory organization for drugs, concluding that Brexit will lead to a "less efficient, more expensive, and potentially lengthier regulatory process" for drug approval in the EU and the U.K. Among the companies that are currently in discussions with the EMA or have drugs under MAA review, Needham lists ACADIA (ACAD) Celator (CPXX), Cempra (CEMP), Gilead (GILD) Intercept (ICPT), Seattle Genetics (SGEN), Valeant (VRX) and Progenics (PGNX).
07/08/16
PIPR
07/08/16
NO CHANGE
Target $44
PIPR
Overweight
Piper reiterates Overweight on ACADIA following physician survey
Piper Jaffray analyst Charles Duncan says his firm's recent survey of U.S. neurologists and psychiatrists who treat Parkinson's disease patients provides further support for his "non-consensus" revenue build for ACADIA's Nuplazid in Parkinson's disease psychosis. Sentiment for the drug is positive, and doctors see value in treating PDP, Duncan tells investors in a research note. He reiterates an Overweight rating on ACADIA with a $44 price target.
08/05/16
AGIS
08/05/16
DOWNGRADE
Target $41
AGIS
Hold
ACADIA downgraded to Hold from Buy at Aegis
Aegis analyst Robert Leboyer downgraded ACADIA Pharmaceuticals to Hold with a $41 price target saying the stock at current levels is fairly valued.

TODAY'S FREE FLY STORIES

ANTM

Anthem

$177.90

-0.4 (-0.22%)

, CI

Cigna

$155.93

-0.28 (-0.18%)

10:13
04/28/17
04/28
10:13
04/28/17
10:13
Periodicals
Breaking Periodicals news story on Anthem, Cigna »

Appeals court upholds…

ANTM

Anthem

$177.90

-0.4 (-0.22%)

CI

Cigna

$155.93

-0.28 (-0.18%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    May

  • 18

    May

RDUS

Radius Health

$38.72

-0.5 (-1.27%)

10:12
04/28/17
04/28
10:12
04/28/17
10:12
Hot Stocks
FDA website shows approval of Radius Health's Tymlos »

Shares of Radius Health…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    May

  • 03

    May

  • 02

    Jun

  • 30

    Jun

WDC

Western Digital

$85.71

1.1 (1.30%)

10:11
04/28/17
04/28
10:11
04/28/17
10:11
Recommendations
Western Digital analyst commentary  »

Western Digital price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VIX

Volatility Index S&P 500 Options

$10.50

0.14 (1.35%)

10:11
04/28/17
04/28
10:11
04/28/17
10:11
Options
Opening action in VIX August calls »

Opening action in VIX…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CLDR

Cloudera

10:10
04/28/17
04/28
10:10
04/28/17
10:10
Syndicate
Breaking Syndicate news story on Cloudera »

Cloudera IPO indicated to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

NVS

Novartis

$76.70

-0.36 (-0.47%)

10:10
04/28/17
04/28
10:10
04/28/17
10:10
Hot Stocks
FDA approves Novartis' combination treatment for AML »

The U.S. Food and Drug…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    May

  • 05

    May

  • 07

    May

  • 06

    Jun

  • 26

    Jun

SWKS

Skyworks

$104.20

1.23 (1.19%)

, SSNLF

Samsung

10:09
04/28/17
04/28
10:09
04/28/17
10:09
Recommendations
Skyworks, Samsung analyst commentary  »

Skyworks price target…

SWKS

Skyworks

$104.20

1.23 (1.19%)

SSNLF

Samsung

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    May

  • 30

    May

RDUS

Radius Health

$38.72

-0.5 (-1.27%)

10:07
04/28/17
04/28
10:07
04/28/17
10:07
Hot Stocks
Radius Health jumps after FDA posts approval of Tymlos 

Reference Link

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    May

  • 03

    May

  • 02

    Jun

  • 30

    Jun

ORLY

O'Reilly Automotive

$257.19

-7.88 (-2.97%)

10:02
04/28/17
04/28
10:02
04/28/17
10:02
Recommendations
O'Reilly Automotive analyst commentary  »

O'Reilly Automotive…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Jun

MHK

Mohawk

$229.91

-8.97 (-3.76%)

10:01
04/28/17
04/28
10:01
04/28/17
10:01
Technical Analysis
Mohawk testing uptrend support line following earnings »

The shares were last at…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

10:01
04/28/17
04/28
10:01
04/28/17
10:01
General news
Consumer Sentiment Index data reported »

April Consumer Sentiment…

CL

Colgate-Palmolive

$72.10

-1.2 (-1.64%)

10:01
04/28/17
04/28
10:01
04/28/17
10:01
Options
Call buyer in Colgate as shares fall on earnings »

Call buyer in Colgate as…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

  • 31

    May

EEX

Emerald Expositions Events

10:00
04/28/17
04/28
10:00
04/28/17
10:00
Syndicate
Breaking Syndicate news story on Emerald Expositions Events »

Emerald Expositions…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

IVC

Invacare

$14.85

1.6 (12.08%)

09:59
04/28/17
04/28
09:59
04/28/17
09:59
Upgrade
Invacare rating change  »

Invacare upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    May

  • 18

    May

CVNA

Carvana

09:58
04/28/17
04/28
09:58
04/28/17
09:58
Syndicate
Breaking Syndicate news story on Carvana »

Carvana opens at $13.50,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

EFX

Equifax

$134.84

-1.35 (-0.99%)

09:56
04/28/17
04/28
09:56
04/28/17
09:56
Downgrade
Equifax rating change  »

Equifax downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    May

  • 04

    May

EEX

Emerald Expositions Events

09:55
04/28/17
04/28
09:55
04/28/17
09:55
Syndicate
Breaking Syndicate news story on Emerald Expositions Events »

Emerald Expositions…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

09:55
04/28/17
04/28
09:55
04/28/17
09:55
General news
U.S. Chicago PMI increased 0.6 points to 58.3 in April »

U.S. Chicago PMI…

CSGP

CoStar Group

$236.71

17.35 (7.91%)

09:53
04/28/17
04/28
09:53
04/28/17
09:53
Recommendations
CoStar Group analyst commentary  »

CoStar Group price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

  • 21

    Jun

  • 22

    Jun

  • 22

    Jun

BOKF

BOK Financial

$85.04

-0.42 (-0.49%)

09:51
04/28/17
04/28
09:51
04/28/17
09:51
Upgrade
BOK Financial rating change  »

BOK Financial upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    May

OCLR

Oclaro

$7.93

0.01 (0.13%)

09:51
04/28/17
04/28
09:51
04/28/17
09:51
Recommendations
Oclaro analyst commentary  »

Oclaro estimates lowered …

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

  • 30

    May

BSX

Boston Scientific

$26.16

-0.02 (-0.08%)

09:51
04/28/17
04/28
09:51
04/28/17
09:51
Options
Active trading in Boston Scientific short-term calls »

Active trading in Boston…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    May

  • 07

    Jun

  • 27

    Jun

EEX

Emerald Expositions Events

09:50
04/28/17
04/28
09:50
04/28/17
09:50
Syndicate
Breaking Syndicate news story on Emerald Expositions Events »

Emerald Expositions…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

09:50
04/28/17
04/28
09:50
04/28/17
09:50
General news
The hefty 0.8% U.S. Q1 ECI gain »

The hefty 0.8% U.S. Q1…

ZYME

Zymeworks

09:49
04/28/17
04/28
09:49
04/28/17
09:49
Syndicate
Breaking Syndicate news story on Zymeworks »

Zymeworks opens at…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.